British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...

GSK plc (NYSE:GSK) has failed to meet key ethical and regulatory standards in how it marketed and provided prescribing information for its drug Omjjara, according to a ruling issued Tuesday by an ...

(Reuters) -British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara drug, an industry self-regulatory body ...

GSK's submission for the approval of Omjjara was supported by data from the pivotal MOMENTUM study and a subpopulation of adult patients with anaemia from the SIMPLIFY-1 phase III trial. MOMENTUM was ...

Earlier treatment options for managing myelofibrosis-related anaemia have demonstrated limited efficacy and durability of response; and while JAK inhibitors are often used, they can sometimes ...